Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
AMEX
Rafael Holdings Inc (RFL)
Rafael Holdings Inc (RFL) News

Rafael (RFL)

Rafael Holdings Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:RFL

1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
06/10/2021	11:30	PR Newswire (US)	Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer	AMEX:RFL	Rafael Holdings Inc
17/09/2021	21:01	PR Newswire (US)	Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08	AMEX:RFL	Rafael Holdings Inc
20/08/2021	12:00	PR Newswire (US)	Rafael Holdings Announces $104.2 Million Private Placement	AMEX:RFL	Rafael Holdings Inc
17/08/2021	15:11	PR Newswire (US)	Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company	AMEX:RFL	Rafael Holdings Inc
30/06/2021	13:00	GlobeNewswire Inc.	Rafael Pharmaceuticals to Present Pancreatic & Biliary Tract Cancer Data on CPI-613® (Devimistat) from its Multicenter, Rand...	AMEX:RFL	Rafael Holdings Inc
29/06/2021	16:00	GlobeNewswire Inc.	FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (Devimistat) for Treatment of Biliary Cancer	AMEX:RFL	Rafael Holdings Inc
23/06/2021	17:39	PR Newswire (US)	Rafael Holdings and Rafael Pharmaceuticals Management Presented at the Raymond James 2021 Human Health Innovation Conference ...	AMEX:RFL	Rafael Holdings Inc
26/05/2021	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals to Present New Pancreatic Cancer and Biliary Tract Cancer Data featuring CPI-613® (Devimistat) at the...	AMEX:RFL	Rafael Holdings Inc
16/04/2021	22:00	PR Newswire (US)	Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08	AMEX:RFL	Rafael Holdings Inc
30/03/2021	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Crosses Enrollment of 150 Patients in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) fo...	AMEX:RFL	Rafael Holdings Inc
19/01/2021	16:30	GlobeNewswire Inc.	Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference	AMEX:RFL	Rafael Holdings Inc
13/01/2021	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference	AMEX:RFL	Rafael Holdings Inc
22/12/2020	13:30	PR Newswire (US)	Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor P...	AMEX:RFL	Rafael Holdings Inc
15/12/2020	16:09	GlobeNewswire Inc.	UPDATE - Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Mye...	AMEX:RFL	Rafael Holdings Inc
15/12/2020	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leuk...	AMEX:RFL	Rafael Holdings Inc
01/12/2020	17:05	GlobeNewswire Inc.	Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimista...	AMEX:RFL	Rafael Holdings Inc
01/12/2020	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimista...	AMEX:RFL	Rafael Holdings Inc
10/11/2020	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Pancreatic Cancer	AMEX:RFL	Rafael Holdings Inc
29/10/2020	13:30	GlobeNewswire Inc.	FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (devimistat) for Treatment of Soft Tissue Sarcoma	AMEX:RFL	Rafael Holdings Inc
27/10/2020	13:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Crosses Enrollment of 100th Patient in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) f...	AMEX:RFL	Rafael Holdings Inc
20/10/2020	14:00	GlobeNewswire Inc.	A New Phase 1 Study Began to Evaluate Rafael Pharmaceuticals’ Lead Compound CPI-613®️ (devimistat) for Patients With Pan...	AMEX:RFL	Rafael Holdings Inc
24/08/2020	13:30	PR Newswire (US)	Rafael Holdings to Present at LD Micro Investor Conference	AMEX:RFL	Rafael Holdings Inc
06/08/2020	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Achieves Target Enrollment of 500 Patients in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ®️ (de...	AMEX:RFL	Rafael Holdings Inc
21/07/2020	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Crosses Midpoint of Enrollment to First Interim Analysis in Pivotal Phase 3 Trial (ARMADA 2000) of CPI...	AMEX:RFL	Rafael Holdings Inc
09/06/2020	22:28	PR Newswire (US)	Rafael Holdings Reports Third Quarter Fiscal Year 2020 Results	AMEX:RFL	Rafael Holdings Inc
09/06/2020	22:25	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:RFL	Rafael Holdings Inc
09/06/2020	22:17	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:RFL	Rafael Holdings Inc
26/05/2020	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals to Present Phase 1 Data on CPI-613® (Devimistat) in Patients with Locally Advanced or Metastatic Panc...	AMEX:RFL	Rafael Holdings Inc
07/05/2020	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Announces In Vivo Study to Evaluate the Effects of CPI-613® (Devimistat) in Combination with Azacitid...	AMEX:RFL	Rafael Holdings Inc
05/05/2020	14:00	GlobeNewswire Inc.	Rafael Pharmaceuticals Enters into Research Collaboration with Roswell Park Comprehensive Cancer Center to Evaluate the Effec...	AMEX:RFL	Rafael Holdings Inc

Showing the most relevant articles for your search:AMEX:RFL

1 2 3 4 5 Next >>

Petrel Resources

Surface Transforms

Gulf Keystone Petroleum

Pantheon Resources

Oxford Biomedica

Supply@me Capital

Sirius Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions